Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000090

Options or other derivatives

  • Director acquired 80,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
DeSilva Nishan M Director 2021-06-23 Grant or award · Stock Option (Right to Buy) +80,000 80,000 D: show line 1 in the form
Loading xslF345X03/wf-form4_162586206787394.xml…